AGP Executive Report
Last update: 8 hours agoMedicaid GLP-1 Cut in Rhode Island: Rhode Island Medicaid will stop covering Wegovy, Zepbound, Saxenda and Foundayo when prescribed only for weight loss starting Oct. 1, 2026—while diabetes-related GLP-1 use remains covered. Health Care Access & Costs: A new analysis of ACA Marketplace enrollment finds plan selections fell 4.9% nationwide as premiums rose 19.7%, reshaping what people can afford. Pediatric Sleep Testing Gaps: A landmark Medicaid study reports kids’ access to sleep studies varies dramatically by location, with some states seeing testing rates up to four times higher than others. Respiratory Season Watch: Rhode Island is entering fall with low COVID-19, flu and RSV levels, but officials say updated immunizations are available now and recommend getting ahead of winter surges. Local Care Network Move: South County Health becomes the first Rhode Island health system to join the Mayo Clinic Care Network, signaling a new model for clinical support. Community Health Event: The Alzheimer’s Association hosts a Walk to End Alzheimer’s in Westerly, highlighting support for the estimated 22,000 Rhode Islanders living with Alzheimer’s and 37,000 caregivers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
